✦ LIBER ✦

Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs for the Treatment of Type 2 Diabetes

✍ Scribed by Dang, Qun; Kasibhatla, Srinivas Rao; Reddy, K. Raja; Jiang, Tao; Reddy, M. Rami; Potter, Scott C.; Fujitaki, James M.; van Poelje, Paul D.; Huang, Jingwei; Lipscomb, William N.

Book ID: 115496840
Publisher: American Chemical Society
Year: 2007
Tongue: English
Weight: 398 KB
Volume: 129
Category: Article
ISSN: 0002-7863
DOI: 10.1021/ja074871l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of Phosphonic Diamide Prodrugs

Discovery of Phosphonic Diamide Prodrugs and Their Use for the Oral Delivery of a Series of Fructose 1,6-Bisphosphatase Inhibitors

✍ Dang, Qun; Kasibhatla, Srinivas Rao; Jiang, Tao; Fan, Kevin; Liu, Yan; Taplin, F 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 145 KB

ChemInform Abstract: Sulfonylureido Thia

ChemInform Abstract: Sulfonylureido Thiazoles as Fructose-1,6-bisphosphatase Inhibitors for the Treatment of Type-2 Diabetes.

✍ Eric Kitas; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 20 KB 👁 1 views

[RSC Drug Discovery] New Therapeutic Str

[RSC Drug Discovery] New Therapeutic Strategies for Type 2 Diabetes Volume 74 || Chapter 11. The Discovery and Development of MB07803, a Second-Generation Fructose-1,6-bisphosphatase Inhibitor with Improved Pharmacokinetic Properties, as a Potential Treatment of Type 2 Diabetes

✍ Jones, Rob M 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 720 KB

Discovery of Phenylpropanoic Acid Deriva

Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes

✍ Mikami, Satoshi; Kitamura, Shuji; Negoro, Nobuyuki; Sasaki, Shinobu; Suzuki, Mas 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 689 KB

Discovery and Preclinical Profile of Sax

Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khan 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 214 KB

ChemInform Abstract: Discovery of Carmeg

ChemInform Abstract: Discovery of Carmegliptin (I): A Potent and Long-Acting Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.

✍ Patrizio Mattei; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 16 KB 👁 2 views